Poland – Various medicinal products – Dostawa leków, preparatów farmaceutycznych, preparatów hemostatycznych, immunoglobulin, leków onkologicznych, kontrastów, środków odkażających i innych na okres 24 miesięcy - program lekowy.”

Part 1 - Injectable cytotoxic drugs (with the possibility of use in the drug program) | Part 2 - Crisantaspase (with the possibility of use in the drug program) | Part 3 - Inotuzumab ozogamicin (with the possibility of use in the drug program) | Part 4 - Brentuximab vedotin (with the possibility of use in the drug program) | Part 5 - Injectable cytotoxic drugs (with the possibility of use in the drug program) | Part 6 - Miscellaneous drugs (with the possibility of use in the drug program) | Part 7 - Blinatumomab (with the possibility of use in the drug program) | Part 8 - Oncological drugs - oral form (with the possibility of use in the drug program) | Part 9 - Rituximab (with the possibility of use in the drug program) | Part 10 - Oncological drugs - injectable form (with the possibility of use in the drug program) | Part 11 - Oncology drugs - oral form (with the possibility of use in the drug program) | Part 12 - Pegasparaginase (with the possibility of use in the drug program) | Part 13 - Pembrolizumab (with the possibility of use in the drug program) | Part 14 - Oncology drugs - oral form (with the possibility of use in the drug program) | Part 15 - Miscellaneous drugs (with the possibility of use in the drug program) | Part 16 - Tocilizumab (with the possibility of use in the drug program) | Part 17 - Miscellaneous drugs (with the possibility of use in the drug program) | Part 18 - Monoclonal antibodies for use in unstable ischemic heart disease (with the possibility of use in the drug program) | Part 19 - Miscellaneous drugs (with the possibility of use in the drug program) | Part 20 - Interferon (with the possibility of use in the drug program) | Part 21 - Miscellaneous drugs (with the possibility of use in the drug program) | Part 22 - Miscellaneous drugs (can be used in the drug program) | Part 23 - Letermovir (can be used in the drug program) | Part 24 - Eculizumab (can be used in the drug program) | Part 25 - Guselkumab (can be used in the drug program)...